Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors-Reference-Cited by-同舟云学术

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors

Published:2016-03 Issue:3 Volume:22 Page:432-440
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Shanavas Mohamed,Popat Uday,Michaelis Laura C.,Fauble Veena,McLornan Donal,Klisovic Rebecca,Mascarenhas John,Tamari Roni,Arcasoy Murat O.,Davies James,Gergis Usama,Ukaegbu Oluchi C.,Kamble Rammurti T.,Storring John M.,Majhail Navneet S.,Romee Rizwan,Verstovsek Srdan,Pagliuca Antonio,Vasu Sumithira,Ernst Brenda,Atenafu Eshetu G.,Hanif Ahmad,Champlin Richard,Hari Paremeswaran,Gupta Vikas

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference37 articles.

1. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms;Lundberg;Blood,2014

2. A gain-of-function mutation of JAK2 in myeloproliferative disorders;Kralovics;N Engl J Med,2005

3. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis;Levine;Cancer Cell,2005

4. A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis;Verstovsek;N Engl J Med,2012

5. JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis;Harrison;N Engl J Med,2012

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Stem Cell Transplantation for Myelofibrosis;Current Hematologic Malignancy Reports;2024-09-06

2. SOHO State of the Art Updates and Next Questions | Choosing and Properly Using a JAK Inhibitor in Myelofibrosis;Clinical Lymphoma Myeloma and Leukemia;2024-09

3. Myelofibrosis and allogeneic transplantation: critical points and challenges;Frontiers in Oncology;2024-06-20

4. The application of JAK inhibitors in the peri-transplantation period of hematopoietic stem cell transplantation for myelofibrosis;Annals of Hematology;2024-03-18

5. Adult Myeloproliferative Disorders/Myelodysplastic Syndromes/Overlap Syndromes;Tata Memorial Centre Textbook of Oncology;2024